Hawkins R A, Hill A, Freedman B, Gore S M, Roberts M M, Forrest A P
Br J Cancer. 1977 Sep;36(3):355-61. doi: 10.1038/bjc.1977.200.
The reproducibility of measurements of oestrogen-receptor activity has been examined in multiple specimens from a rabbit uterus, a rat mammary tumour and human breast tumours. The relationship between receptor concentration and tumour histology has also been investigated in 11 large primary tumours. In the animal tissues, receptor measurements were relatively reproducible (coefficient of variance: wet wt. basis 16-17%, protein basis 16-21%) but in human breast tumours receptor activity varied considerably (c.v.: wet wt. basis, 22-125%; protein basis, 28-72%). In addition to these variations in receptor activity within tumours, there was a difference between tumours, as demonstrated by an analysis of variance (P less than 0.01). In the 11 primary breast cancers selected for study, the level of receptor activity was related to menopausal status and the tumour content of the specimen. We conclude that the receptor activity detected varies within a tumour and depends upon the tumour content of the biopsy specimen. Predictions based on precise quantitation of receptor concentrations may therefore necessitate replicate tumour sampling and correction for the fraction of non-tumour tissue in each sample.
已在取自兔子宫、大鼠乳腺肿瘤和人类乳腺肿瘤的多个样本中检测了雌激素受体活性测量的可重复性。还对11个大型原发性肿瘤中受体浓度与肿瘤组织学之间的关系进行了研究。在动物组织中,受体测量相对具有可重复性(变异系数:以湿重计为16 - 17%,以蛋白质计为16 - 21%),但在人类乳腺肿瘤中,受体活性差异很大(变异系数:以湿重计为22 - 125%;以蛋白质计为28 - 72%)。除了肿瘤内受体活性的这些变化外,肿瘤之间也存在差异,方差分析表明(P小于0.01)。在所选用于研究的11例原发性乳腺癌中,受体活性水平与绝经状态和样本的肿瘤含量有关。我们得出结论,所检测到的受体活性在肿瘤内存在差异,并且取决于活检样本中的肿瘤含量。因此,基于受体浓度精确定量的预测可能需要重复进行肿瘤采样,并对每个样本中非肿瘤组织的比例进行校正。